Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies

Cancer Science

Volumn 103, Issue 7, 2012, Pages 1230-1237

  Rokstad, Anne M ^a   Gustafsson, Björn I ^a,b   Espevik, Terje ^a   Bakke, Ingunn ^a   Pfragner, Roswitha ^c   Svejda, Bernhard ^c   Modlin, Irvin M ^d   Kidd, Mark ^d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALGINIC ACID; BARIUM ION; CALCIUM ION; CYCLIC AMP; MICROSPHERE; SEROTONIN;

ARTICLE; BIOREACTOR; CELL ASSAY; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL SURVIVAL; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MICROENCAPSULATION; NEUROSECRETORY CELL; PRIORITY JOURNAL; TUMOR CELL;

ADRENERGIC BETA-AGONISTS; ALGINATES; BARIUM; BIOCOMPATIBLE MATERIALS; CALCIUM; CAPSULES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FORSKOLIN; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INTESTINE, SMALL; ISOPROTERENOL; MICROSCOPY, CONFOCAL; MICROSPHERES; MODELS, BIOLOGICAL; NEUROENDOCRINE TUMORS; SEROTONIN; SPHEROIDS, CELLULAR; TIME FACTORS;

EID: 84863306599     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02282.x     Document Type: Article

References (50)

1. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: Alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil 2007; 19: 25-31.
2. Ghia JE, Li N, Wang H et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology 2009; 137: 1649-60.
3. de Herder WW. Biochemistry of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007; 21: 33-41.
4. Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst 2008; 100: 1282-9.
5. Modlin IM, Oberg K, Chung DC et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9: 61-72.
6. Lawrence B, Gustafsson BI, Kidd M, Modlin I. New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors. Gastroenterol Clin North Am 2010; 39: 615-28.
7. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001; 50: 1698-705.
8. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-10.
9. Omer A, Duvivier-Kali VF, Trivedi N, Wilmot K, Bonner-Weir S, Weir GC. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 2003; 52: 69-75.
10. Qi M, Strand BL, Morch Y et al. Encapsulation of human islets in novel inhomogeneous alginate-ca2+/ba2+ microbeads: In vitro and in vivo function. Artif Cells Blood Substit Immobil Biotechnol 2008; 36: 403-20.
11. Read TA, Sorensen DR, Mahesparan R et al. Local endostatin treatment of gliomas administered by microencapsulated cells. Nat Biotechnol 2001; 19: 29-34.
12. Cirone P, Bourgeois JM, Austin RC, Chang PL. A novel approach to tumor suppression with microencapsulated recombinant cells. Hum Gene Ther 2002; 13: 1157-66.
13. Cirone P, Bourgeois JM, Chang PL. Antiangiogenic cancer therapy with microencapsulated cells. Hum Gene Ther 2003; 14: 1065-77.
14. Goren A, Gilert A, Meyron-Holtz E, Melamed D, Machluf M. Alginate encapsulated cells secreting Fas-ligand reduce lymphoma carcinogenicity. Cancer Sci 2011; 20: 1349-7006.
15. Joki T, Machluf M, Atala A et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001; 19: 35-9.
16. Smidsrod O, Skjak-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol 1990; 8: 71-8.
17. Morch YA, Donati I, Strand BL, Skjak-Braek G. Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. Biomacromolecules 2006; 7: 1471-80.
18. Donati I, Holtan S, Morch YA, Borgogna M, Dentini M, Skjak-Braek G. New hypothesis on the role of alternating sequences in calcium-alginate gels. Biomacromolecules 2005; 6: 1031-40.
19. Morch YA, Donati I, Strand BL, Skjak-Braek G. Molecular engineering as an approach to design new functional properties of alginate. Biomacromolecules 2007; 8: 2809-14.
20. Morch YA, Holtan S, Donati I, Strand BL, Skjak-Braek G. Mechanical properties of C-5 epimerized alginates. Biomacromolecules 2008; 9: 2360-8.
21. Strand BL, Morch YA, Espevik T, Skjak-Braek G. Visualization of alginate-poly-L-lysine-alginate microcapsules by confocal laser scanning microscopy. Biotechnol Bioeng 2003; 82: 386-94.
22. Thu B, Bruheim P, Espevik T, Smidsrod O, Soon-Shiong P, Skjak-Braek G. Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 1996; 17: 1031-40.
23. Strand BL, Morch YA, Syvertsen KR, Espevik T, Skjak-Braek G. Microcapsules made by enzymatically tailored alginate. J Biomed Mater Res A 2003; 64: 540-50.
24. Thu B, Bruheim P, Espevik T, Smidsrod O, Soon-Shiong P, Skjak-Braek G. Alginate polycation microcapsules. II. Some functional properties. Biomaterials 1996; 17: 1069-79.
25. Rokstad AM, Holtan S, Strand B et al. Microencapsulation of cells producing therapeutic proteins: optimizing cell growth and secretion. Cell Transplant 2002; 11: 313-24.
26. Rokstad AM, Strand B, Rian K et al. Evaluation of different types of alginate microcapsules as bioreactors for producing endostatin. Cell Transplant 2003; 12: 351-64.
27. Constantinidis I, Rask I, Long RC Jr, Sambanis A. Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped beta TC3 mouse insulinoma cells. Biomaterials 1999; 20: 2019-27.
28. Peirone M, Ross CJ, Hortelano G, Brash JL, Chang PL. Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. J Biomed Mater Res 1998; 42: 587-96.
29. Rokstad AM, Donati I, Borgogna M et al. Cell-compatible covalently reinforced beads obtained from a chemoenzymatically engineered alginate. Biomaterials 2006; 27: 4726-37.
30. Pfragner R, Wirnsberger G, Niederle B et al. Establishment of a continuous cell line from human carcinoid of the small intestine (KRJ-1): Characterization and effect of 5-azacytidine on proliferation. Int J Oncol 1996; 8: 513-20.
31. Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC. The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab 2006; 91: 2340-8.
32. Kidd M, Eick GN, Modlin IM, Pfragner R, Champaneria MC, Murren J. Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin. J Mol Endocrinol 2007; 38: 181-92.
33. Kidd M, Modlin IM, Shapiro MD et al. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol 2007; 13: 5208-16.
34. Kidd M, Schally AV, Pfragner R, Malfertheiner MV, Modlin IM. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors. Cancer 2008; 112: 1404-14.
35. Kidd M, Drozdov I, Joseph R, Pfragner R, Culler M, Modlin I. Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines. Cancer 2008; 113: 690-700.
36. Gustafsson BI, Bakke I, Hauso O et al. Parietal cell activation by arborization of ECL cell cytoplasmic projections is likely the mechanism for histamine induced secretion of hydrochloric acid. Scand J Gastroenterol 2011; 46: 531-7.
37. Kidd M, Modlin IM, Gustafsson BI, Drozdov I, Hauso O, Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol Gastrointest Liver Physiol 2008; 295: G260-72.
38. Helmlinger G, Netti PA, Lichtenbeld HC, Melder RJ, Jain RK. Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol 1997; 15: 778-83.
39. Martinsen A, Skjak-Braek G, Smidsrod O. Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng 1989; 33: 79-89.
40. Sakai S, Hashimoto I, Kawakami K. Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid praffin and formation of embryoid body-like spherical tissues from mouse EC cells enclosed within microcapsules. Biotechnol Bioeng 2008; 99: 235-43.
41. Orive G, Herandez RM, Gascon AR, Igartua M, Pedraz JL. Survival of different cell lines in alginate-agarose microcapsules. Eur J Pharm Sci 2003; 18: 23-30.
42. Kulseng B, Thu B, Espevik T, Skjak-Braek G. Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant 1997; 6: 387-94.
43. King A, Sandler S, Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 2001; 57: 374-83.
44. Safley SA, Cui H, Cauffiel S, Tucker-Burden C, Weber CJ. Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly-L-lysine microcapsules versus barium alginate microcapsules without poly-L-lysine. J Diabetes Sci Technol 2008; 2: 760-7.
45. Strand BL, Ryan TL, In't Veld P et al. Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 2001; 10: 263-75.
46. Rokstad AM, Brekke OL, Steinkjer B et al. Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater 2011; 7: 2566-78.
47. Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil 2009; 21: 439-50.
48. Friedrich J, Ebner R, Kunz-Schughart LA. Experimental anti-tumor therapy in 3-D: spheroids-Old hat or new challenge? Int J Radiat Biol 2007; 83: 849-71.
49. Huang S, Ingber DE. Cell tension, matrix mechanics, and cancer development. Cancer Cell 2005; 8: 175-6.
50. Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, Mooney DJ. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci USA 2009; 106: 399-404.